Works by Panayiotidis, P.

Results: 21
    1
    2

    What Does Apoptosis Mean in CLL??

    Published in:
    Leukemia & Lymphoma, 1996, v. 22, n. S2, p. 47, doi. 10.3109/10428199609102702
    By:
    • Binet, J. L.;
    • Plunkett, W.;
    • Robertson, B.;
    • Merle-Beral, H.;
    • Mentz, F.;
    • Hoffbrand, A. V.;
    • Panayiotidis, P.
    Publication type:
    Article
    3

    P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY.

    Published in:
    HemaSphere, 2022, v. 6, p. 1527, doi. 10.1097/01.HS9.0000849440.55427.b0
    By:
    • Pontikoglou, C.;
    • Matheakakis, A.;
    • Stavroulaki, E.;
    • Chatzilygeroudi, T.;
    • Kourakli, A.;
    • Symeonidis, A.;
    • Dimou, M.;
    • Panayiotidis, P.;
    • Drakos, G.;
    • Koudouna, A.;
    • Galanopoulos, A.;
    • Kaliafentaki, V.;
    • Kanellou, P.;
    • Liapi, D.;
    • Tsirakis, G.;
    • Kolovou, A.;
    • Gavriilaki, E.;
    • Syrigou, A.;
    • Sakellari, I.;
    • Chatzileontiadou, S.
    Publication type:
    Article
    4

    P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL.

    Published in:
    HemaSphere, 2022, v. 6, p. 1028, doi. 10.1097/01.HS9.0000847420.24995.43
    By:
    • Zinzani, P. L.;
    • Özcan, M.;
    • Sapunarova, K.;
    • Jurczak, W.;
    • Hamed, A.;
    • Bouabdallah, K.;
    • Saydam, G.;
    • Geissler, K.;
    • Szomor, Á.;
    • Lazaroiu, M.;
    • Salar, A.;
    • Tempescul, A.;
    • Nalcaci, M.;
    • Gercheva, L.;
    • Egyed, M.;
    • Panayiotidis, P.;
    • Mongay Soler, L.;
    • Cao, A.;
    • Phelps, C.;
    • H Childs, B.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B-CELL LYMPHOMA (CHRONOS-1).

    Published in:
    Hematological Oncology, 2017, v. 35, p. 119, doi. 10.1002/hon.2437_107
    By:
    • Dreyling, M.;
    • Santoro, A.;
    • Mollica, L.;
    • Leppä, S.;
    • Follows, G.A.;
    • Lenz, G.;
    • Kim, W.;
    • Nagler, A.;
    • Panayiotidis, P.;
    • Demeter, J.;
    • Özcan, M.;
    • Kosinova, M.;
    • Bouabdallah, K.;
    • Morschhauser, F.;
    • Stevens, D.A.;
    • Trevarthen, D.;
    • Giurescu, M.;
    • Liu, L.;
    • Koechert, K.;
    • Peña, C.
    Publication type:
    Article
    14

    Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.

    Published in:
    Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
    By:
    • Sarris, Katerina;
    • Maltezas, Dimitrios;
    • Koulieris, Efstathios;
    • Bartzis, Vassiliki;
    • Tzenou, Tatiana;
    • Sachanas, Sotirios;
    • Nikolaou, Eftychia;
    • Efthymiou, Anna;
    • Bitsani, Katerina;
    • Dimou, Maria;
    • Vassilakopoulos, Theodoros P.;
    • Siakantaris, Marina;
    • Angelopoulou, Maria K.;
    • Kontopidou, Flora;
    • Tsaftaridis, Panagiotis;
    • Kafasi, Nikolitsa;
    • Pangalis, Gerasimos A.;
    • Panayiotidis, Panayiotis P.;
    • Harding, Stephen;
    • Kyrtsonis, Marie-Christine
    Publication type:
    Article
    15

    Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant.

    Published in:
    2010
    By:
    • Koren-Michowitz M;
    • le Coutre P;
    • Duyster J;
    • Scheid C;
    • Panayiotidis P;
    • Prejzner W;
    • Rowe JM;
    • Schwarz M;
    • Goldschmidt N;
    • Nagler A;
    • Koren-Michowitz, Maya;
    • le Coutre, Philipp;
    • Duyster, Justus;
    • Scheid, Christof;
    • Panayiotidis, Panayiotis;
    • Prejzner, Witold;
    • Rowe, Jacob M;
    • Schwarz, Michaela;
    • Goldschmidt, Neta;
    • Nagler, Arnon
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21